Name | Symbol | Markt | Aktientyp |
---|---|---|---|
NLS Pharmaceutics Ltd | NLSPW | NASDAQ | Equity Warrant |
Handelsbeginn | Niedrig | Hoch | Schlusskurs | Handelsende |
---|---|---|---|---|
0,026 | 0,026 | 0,029723 | 0,029723 | 0,026 |
Aktuelle News
Datum | Zeit | Quelle | Überschrift |
---|---|---|---|
11.6.2024 | 22:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
06.6.2024 | 23:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
31.5.2024 | 23:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
28.5.2024 | 15:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
24.5.2024 | 23:25 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
22.5.2024 | 15:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
14.5.2024 | 22:26 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |